LungBlog

The worst lines readers have heard.

SwedishAmerican Health System has begun a Multidisciplinary Lung Cancer Center (MLCC). The MLCC is a group of specialists brought together to evaluate patients with known or suspected lung tumors in a timely and coordinated manner.

The researchers found a 24 percent increase in lung cancer risk among people exposed to passive smoke in the workplace. Workers who were highly exposed had a 100 percent increased (or doubled) risk of lung cancer, and workers with a long history, or duration, of exposure to passive smoke had a 50 percent increased risk.

Multi-drug chemotherapy resistance in non–small cell lung cancer tumor cultures is common, and associations between molecular markers and in vitro chemotherapy resistance are noted. Clinical validation through integration of such testing into clinical trials seems warranted.

Lauren Terrazzano, who writes a weekly column for Newsday called “Life, With Cancer,” said that for a younger person, “cancer can be the ultimate form of identity theft, if you let it.”

Ms. Terrazzano was told she had advanced lung cancer in 2004 and has since undergone three operations, including an extrapleural pneumonectomy, in which her right lung and part of the lining of her heart were removed. She has also undergone extensive chemotherapy and radiation.

“One day you’re a healthy 36-year-old with long hair, black mascara and low-rider jeans,” she said. “You’re going through the rhythms of life, going to work, going to dinner, hanging out with friends. And the next minute you’re Cancer Girl.

“It’s a hard thing to reconcile.”

“You hear about lung cancer and people not surviving, and it’s just scary,” said Currier. 

But new technology is making lung cancers easier to diagnose earlier. 

An electromagnetic navigation diagnostic bronchoscopy, similar to the global positioning system in cars, lets doctors reach lung cancers they could not reliably reach before.

Chris Conner, a South Carolina musician and frontman for The South who was recently diagnosed with lung cancer, is still writing songs and hanging out with his son, Ace.

And he got married Saturday.

A P.E.I. pharmaceutical company has signed a contract to make an experimental lung cancer drug for human clinical testing.BioVectra DCL will produce L-DOS47 for Helix BioPharma Corp. of Aurora, Ont. Helix specializes in developing cancer therapies

 What you cough up in the morning could help diagnose lung cancer, according to research conducted at the University of Maryland School of Medicine.

Biomoda, Inc. of Albuquerque, NM, maker of early lung cancer detection testing and other cancer diagnostic technology, announced its membership in BIOCOM,  a premier life science industry association that focuses on capital formation, public policy, workforce development, and scientific discovery and development.